@article{a2de7da41db04d65ac387b51a9f96728,
title = "Impact of global geographic region on time in therapeutic range on warfarin anticoagulant therapy: data from the ROCKET AF clinical trial",
abstract = "Vitamin K antagonist (VKA) therapy remains the most common method of stroke prevention in patients with atrial fibrillation. Time in therapeutic range (TTR) is a widely cited measure of the quality of VKA therapy. We sought to identify factors associated with TTR in a large, international clinical trial.",
author = "{ROCKET AF Investigators} and Singer, {Daniel E} and Hellkamp, {Anne S} and Piccini, {Jonathan P} and Mahaffey, {Kenneth W} and Yuliya Lokhnygina and Guohua Pan and Halperin, {Jonathan L} and Becker, {Richard C} and G{\"u}nter Breithardt and Hankey, {Graeme J} and Werner Hacke and Nessel, {Christopher C} and Patel, {Manesh R} and Califf, {Robert M} and Fox, {Keith A A}",
year = "2013",
month = feb,
doi = "10.1161/JAHA.112.000067",
language = "English",
volume = "2",
pages = "e000067",
journal = "Journal of the American Heart Association Cardiovascular and Cerebrovascular Disease",
issn = "2047-9980",
publisher = "Wiley Open Access",
number = "1",
}